Effect of dominant negative transforming growth factor-β receptor type II on cytotoxic activity of RAW 264.7, a murine macrophage cell line

被引:20
|
作者
Lee, Geun Taek
Hong, Jun Hyuk
Kwak, Cheol
Woo, Jaesung
Liu, Victoria
Lee, Chung
Kim, Isaac Yi
机构
[1] Univ Med & Dent New Jersey, Canc Inst New Jersey, Div Urol Oncol, New Brunswick, NJ USA
[2] Univ Ulsan, Coll Med, Dept Urol, Seoul, South Korea
[3] Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA
关键词
D O I
10.1158/0008-5472.CAN-06-4263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor-beta (TGF-beta) is a potent suppressor of the immune system. In the present study, we investigated the effect of TGF-beta resistance on a murine macrophage cell line. RAW 264.7, by overexpressing a dominant negative TGF-beta receptor type II (T beta RIIDN) construct. As expected, T beta IIDN-expressing RAW cells, designated as RAW-T beta RIIDN, were resistant to TGF-beta signaling. When these cells were cocultured with the murine renal cell carcinoma cell line, Renca, a dramatic increase in apoptosis of Renca cells was observed. Simultaneously, elevated levels of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha, (TNF-alpha) in association with IFN-gamma were detected in RAW-T beta RIIDN cells. When the effects of TNF-alpha and iNOS were neutralized through the use of neutralizing antibody and N-G-methyl-L-arginine, respectively, the enhanced cytotoxicity of T beta RIIDN-RAW cells was partially reversed. Taken together, these results show that TGF-beta-resistant RAW 264.7 murine macrophage cells have increased cytotoxic activity that is in part mediated by iNOS and TNF-alpha.
引用
收藏
页码:6717 / 6724
页数:8
相关论文
共 50 条
  • [31] A kinase-defective transforming growth factor-β receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells
    Ko, Y
    Koli, KM
    Banerji, SS
    Li, WH
    Zborowska, E
    Willson, JKV
    Brattain, MG
    Arteaga, CL
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (01) : 87 - 94
  • [32] SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor
    Liu, Sheng
    Nheu, Thao
    Luwor, Rodney
    Nicholson, Sandra E.
    Zhu, Hong-Jian
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (29) : 17894 - 17908
  • [33] Transforming growth factor-β antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor
    Zhang, FJ
    Nielsen, LD
    Lucas, JJ
    Mason, RJ
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (06) : 679 - 686
  • [34] Microsatellite mutation of type II transforming growth factor-β receptor is rare in atherosclerotic plaques
    Clark, KJ
    Cary, NR
    Grace, AA
    Metcalfe, JC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 555 - 559
  • [35] Lack of transforming growth factor-β type II receptor expression in human retinoblastoma cells
    Horie, K
    Yamashita, H
    Mogi, A
    Takenoshita, S
    Miyazono, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 175 (03) : 305 - 313
  • [36] Relation of type II transforming growth factor-β receptor to hepatic fibrosis and hepatocellular carcinoma
    Ueno, T
    Hashimoto, O
    Kimura, R
    Torimura, T
    Kawaguchi, T
    Nakamura, T
    Sakata, R
    Koga, H
    Sata, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (01) : 49 - 55
  • [37] Methylation silencing of transforming growth factor-β receptor type II in rat prostate cancers
    Yamashita, Satoshi
    Takahashi, Satoru
    McDonell, Nathalie
    Watanabe, Naoko
    Niwa, Tohru
    Hosoya, Kosuke
    Tsujino, Yoshimi
    Shirai, Tomoyuki
    Ushijima, Toshikazu
    CANCER RESEARCH, 2008, 68 (07) : 2112 - 2121
  • [38] Inhibitory effect of ferulic acid on macrophage inflammatory protein-2 production in a murine macrophage cell line, RAW264.7
    Sakai, S
    Ochiai, H
    Nakajima, K
    Terasawa, K
    CYTOKINE, 1997, 9 (04) : 242 - 248
  • [39] Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth
    Smith, JD
    Bryant, SR
    Couper, LL
    Vary, CPH
    Gotwals, PJ
    Koteliansky, VE
    Lindner, V
    CIRCULATION RESEARCH, 1999, 84 (10) : 1212 - 1222
  • [40] Mechanism of induction of transforming growth factor-β type II receptor gene expression by v-Src in murine myeloid cells
    Park, SH
    Birchenall-Roberts, MC
    Yi, YS
    Lee, BI
    Lee, DK
    Bertolette, DC
    Fu, T
    Ruscetti, F
    Kim, SJ
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (01): : 9 - 18